Author: Han, Juqiang; Zhang, Xiang
Title: Complement Component C3: A Novel Biomarker Participating in the Pathogenesis of Non-alcoholic Fatty Liver Disease Cord-id: ilvkevjo Document date: 2021_7_29
ID: ilvkevjo
Snippet: Non-alcoholic fatty liver disease (NAFLD) is currently the most common cause of chronic liver disorder worldwide. The pathological spectrum of NAFLD ranges from simple steatosis to non-alcoholic steatohepatitis (NASH) that induces progressive liver cirrhosis and eventually hepatocellular carcinoma (HCC). However, the molecular mechanisms driving the transformation of NASH are obscure. There is a compelling need for understanding the pathogenic mechanisms of NASH, and thereby providing new insigh
Document: Non-alcoholic fatty liver disease (NAFLD) is currently the most common cause of chronic liver disorder worldwide. The pathological spectrum of NAFLD ranges from simple steatosis to non-alcoholic steatohepatitis (NASH) that induces progressive liver cirrhosis and eventually hepatocellular carcinoma (HCC). However, the molecular mechanisms driving the transformation of NASH are obscure. There is a compelling need for understanding the pathogenic mechanisms of NASH, and thereby providing new insight into mechanism-based therapy. Currently, several studies reported that complement system, an innate immune system, played an important role in the pathogenesis of NAFLD, which was also proved by our recent study. Complement component 3 (C3), a protein of the innate immune system, plays a hub role in the complement system. Herein, we present a review on the role and molecular mechanism of C3 in NASH as well as its implication in NASH diagnosis and treatment.
Search related documents:
Co phrase search for related documents- activation recruitment and adaptive innate immunity: 1, 2, 3, 4
- activation recruitment and adoptive transfer: 1
- activation recruitment and liver cell: 1
- activation recruitment and liver disease: 1, 2
- activation recruitment and liver fibrosis: 1
- activation recruitment and liver inflammation: 1, 2
- activation recruitment and liver macrophage: 1
- activation recruitment and liver steatosis: 1
- activation recruitment and logistic regression analysis: 1
- activation recruitment and low density: 1
- activation recruitment and lymphocyte ratio: 1
- activation recruitment and macrophage activation: 1, 2, 3, 4, 5, 6, 7, 8, 9
- activation recruitment and macrophage control: 1
- activity inhibit and adaptive innate: 1
- activity inhibit and adoptive transfer: 1
- activity inhibit and low density: 1, 2, 3
- activity inhibit and low density lipoprotein: 1, 2
- activity inhibit and lymphocyte ratio: 1
- activity inhibit and lymphocyte ratio neutrophil: 1
Co phrase search for related documents, hyperlinks ordered by date